Abstract:Background: Obesity and hypertension are major risk factors for cardiovascular diseases that affect millions of people worldwide. Both conditions are associated with chronic low-grade inflammation, which is mediated by adipokines such as adiponectin. Adiponectin is the most abundant adipokine that has a beneficial impact on metabolic and vascular biology, while high serum concentrations are associated with some syndromes. This "adiponectin paradox" still needs to be clarified in obesity-associated hypertension. The aim of this study was to investigate how adiponectin affects blood pressure, inflammation, and metabolic function in obesity hypertension using a Chinese adult case-control study. Methods: A case-control study that had finished recruiting 153 subjects divided as four characteristic groups. Adiponectin serum levels were tested by ELISA in these subjects among these four characteristic Chinese adult physical examination groups. Waist circumference (WC), body mass index (BMI), systolic blood pressure (SB), diastolic blood pressure (DB), and other clinical laboratory data were collected. Analyzation of correlations between the research index and differences between groups was done by SPSS. Results: Serum adiponectin levels in the| normal healthy group (NH group) were significantly higher than those in the newly diagnosed untreated just-obesity group (JO group), and negatively correlated with the visceral adiposity index. With multiple linear egression analysis, it was found that, for serum adiponectin, gender, serum albumin (ALB), alanine aminotransferase (ALT) and high-density lipoprotein cholesterol (HDLC) were the significant independent correlates, and for SB, age and HDLC were the significant independent correlates, and for DB, alkaline phosphatase (ALP) was the significant independent correlate. The other variables did not reach significance in the model. Conclusions: Our study reveals that adiponectin's role in obesity-hypertension is multifaceted and is influenced by the systemic metabolic homeostasis signaling axis. In obesity-related hypertension, compensatory effects, adiponectin resistance, and reduced adiponectin clearance from impaired kidneys and liver all contribute to the "adiponectin paradox".

Transcription and post-translational mechanisms: dual regulation of adiponectin-mediated Occludin expression in diabetes

Effect of adiponectin on obesity-linked diseases

Abstract 12253: Occludin as a Key Mediator in Adiponectin-Mediated Diabetic Vascular Protection

Mechanism of Action and Risk Prediction of Adiponectin in Cardiovascular Diseases

[Research progress in regulation of adiponectin receptors expression].

Tracking adiponectin biodistribution via fluorescence molecular tomography indicates increased vascular permeability after streptozotocin-induced diabetes

Recent Advances on Adiponectin Receptor

New advances of adiponectin in regulating obesity and related metabolic syndromes

Role of Adiponectin in Cardiovascular Diseases Related to Glucose and Lipid Metabolism Disorders

Adiponectin Self-Regulates Its Expression and Multimerization in Adipose Tissue: an Autocrine/paracrine Mechanism?

Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease

Overexpression of Adiponectin Receptors Potentiates the Antiinflammatory Action of Subeffective Dose of Globular Adiponectin in Vascular Endothelial Cells.

Identification of key genes and mechanisms of epicardial adipose tissue in patients with diabetes through bioinformatic analysis

Adiponectin mRNA Conjugated with Lipid Nanoparticles Specifically Targets the Pathogenesis of Type 2 Diabetes

Reevaluating Adiponectin's impact on obesity hypertension: a Chinese case-control study

Unveiling the multifaceted role of adropin in various diseases (Review)

The role and possible mechanism of lncRNA AC092159.2 in modulating adipocyte differentiation.

Insight into the Effects of Adipose Tissue Inflammation Factors on Mir-378 Expression and the Underlying Mechanism

The role of adiponectin in type 2 diabetes-related periodontitis

Integrative Analysis of a Cross-Loci Regulation Network Identifies App As a Gene Regulating Insulin Secretion from Pancreatic Islets

Negative Regulation of Adiponectin Receptor 1 Promoter by Insulin Via a Repressive Nuclear Inhibitory Protein Element